GGrantIndex
← Leaderboards

Niall John Lennon

Brigham And Women'S Hospital

$26,830,465
Attributed
$78,941,075
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $40.5M · FY201625
$50M$37.5M$25M$12.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$78,941,075 · 6

By mechanism

OT2$49,829,279 · 1
U01$21,107,261 · 2
UM1$6,922,231 · 1
UH3$761,769 · 1
UH2$320,535 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Genomics

Research focus

GenomicsValidationCollaborationsSuccessGenomeResourcesResearch PersonnelCommunitiesData AnalysesGenotypeDesignParticipantInnovationLaboratoriesPhenotypeProgramsCohortPatient OrientedGenomic DataNational Human Genome Research InstituteReportingManuscriptsGenomic MedicineMember

Grant awards (25)

Broad-Color: The Genome Center for the Future of All of Us$13,816,032
OT2 · FY2025 · OD
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$3,080,661
UM1 · FY2025 · DA
Broad-Color: The Genome Center for the Future of All of Us$150,000
OT2 · FY2025 · OD
Broad-Color: The Genome Center for the Future of All of Us$35,863,247
OT2 · FY2024 · OD
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$2,831,245
UM1 · FY2024 · DA
The eMERGE Risk Assessment Network - Coordinating Center$797,761
U01 · FY2024 · HG
Invitae Supplement 2: eMERGE Risk Assessment Network Coordinating Center$766,250
U01 · FY2024 · HG
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers$193,674
UH3 · FY2024 · CA · contact PI
Exploration and benchmarking of duplex sequencing$88,916
UM1 · FY2024 · DA
The eMERGE Risk Assessment Network - Coordinating Center$1,715,221
U01 · FY2023 · HG
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$921,409
UM1 · FY2023 · DA
Invitae Supplement: eMERGE Risk Assessment Network Coordinating Center$442,104
U01 · FY2023 · HG
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers$274,067
UH3 · FY2023 · CA · contact PI
The eMERGE Risk Assessment Network - Coordinating Center$4,219,561
U01 · FY2022 · HG
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers$294,028
UH3 · FY2022 · CA · contact PI
The eMERGE Risk Assessment Network - Coordinating Center$4,221,595
U01 · FY2021 · HG
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers$105,636
UH2 · FY2021 · CA · contact PI
The eMERGE Risk Assessment Network - Coordinating Center$2,453,046
U01 · FY2020 · HG
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers$214,899
UH2 · FY2020 · CA · contact PI
EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY$150,381
U01 · FY2019 · HG
EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY$414,315
U01 · FY2018 · HG
EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY$249,619
U01 · FY2018 · HG
EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY$1,701,070
U01 · FY2017 · HG
Global Alliance for Genomic Health (GA4GH)$450,000
U01 · FY2017 · HG
EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY$3,526,338
U01 · FY2016 · HG